Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease

Authors:

Abstract
Nicotine Treatment and Parkinson's DiseaseIn this randomized, controlled trial, patients with Parkinson's disease not on dopaminergic therapy were randomly assigned to receive transdermal nicotine or placebo. After 1 year, there was no difference in the change in Total Unified Parkinson's Disease Rating Scale score between groups.

This publication has 33 references indexed in Scilit: